Additive Antinociception between Intrathecal Sildenafil and Morphine in the Rat Formalin Test

The possible characteristics of spinal interaction between sildenafil (phosphodiesterase 5 inhibitor) and morphine on formalin-induced nociception in rats was examined. Then the role of the opioid receptor in the effect of sildenafil was further investigated. Catheters were inserted into the intrathecal space of male Sprague-Dawley rats. For induction of pain, 50 µL of 5% formalin solution was applied to the hind-paw. Isobolographic analysis was used for the evaluation of drug interaction between sildenafil and morphine. Furthermore, naloxone was intrathecally given to verify the involvement of the opioid receptor in the antinociception of sildenafil. Both sildenafil and morphine produced an antinociceptive effect during phase 1 and phase 2 in the formalin test. The isobolographic analysis revealed an additive interaction after intrathecal delivery of the sildenafil-morphine mixture in both phases. Intrathecal naloxone reversed the antinociception of sildenafil in both phases. These results suggest that sildenafil, morphine, and the mixture of the two drugs are effective against acute pain and facilitated pain state at the spinal level. Thus, the spinal combination of sildenafil with morphine may be useful in the management of the same state. Furthermore, the opioid receptor is contributable to the antinocieptive mechanism of sildenafil at the spinal level.

[1]  C. Stief,et al.  Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. , 2006, European urology.

[2]  H. Bae,et al.  Synergistic antinociception between zaprinast and morphine in the spinal cord of rats on the formalin test , 2006, European journal of anaesthesiology.

[3]  F. Pérez-Severiano,et al.  Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats. , 2005, European journal of pharmacology.

[4]  G. Castañeda-Hernández,et al.  Probable activation of the opioid receptor-nitric oxide-cyclic GMP-K+ channels pathway by codeine , 2005, Pharmacology Biochemistry and Behavior.

[5]  A. Perez,et al.  δ-Opioid receptor agonist SNC80 elicits peripheral antinociception via δ1 and δ2 receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway , 2005 .

[6]  C. S. Patil,et al.  Modulatory Effect of Cyclooxygenase Inhibitors on Sildenafil-Induced Antinociception , 2003, Pharmacology.

[7]  Long-chuan Yu,et al.  Involvement of oxytocin in spinal antinociception in rats with inflammation , 2003, Brain Research.

[8]  J. Choi,et al.  Pharmacologic Interaction between Cannabinoid and either Clonidine or Neostigmine in the Rat Formalin Test , 2003, Anesthesiology.

[9]  C. S. Patil,et al.  Sildenafil, a Phosphodiesterase-5 Inhibitor, Enhances the Antinociceptive Effect of Morphine , 2003, Pharmacology.

[10]  C. S. Patil,et al.  Sildenafil-induced peripheral analgesia and activation of the nitric oxide–cyclic GMP pathway , 2001, Brain Research.

[11]  J. E. Torres-López,et al.  Sildenafil increases diclofenac antinociception in the formalin test. , 2001, European journal of pharmacology.

[12]  W. A. Prado,et al.  The dual effect of a nitric oxide donor in nociception , 2001, Brain Research.

[13]  K. Jhamandas,et al.  Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs. , 2000, European Journal of Pharmacology.

[14]  V. Granados-Soto,et al.  Sildenafil produces antinociception and increases morphine antinociception in the formalin test. , 2000, European journal of pharmacology.

[15]  T. Nishiyama.  Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test. , 2000, European journal of pharmacology.

[16]  R. Johns,et al.  Expression and action of cyclic GMP-dependent protein kinase Iα in inflammatory hyperalgesia in rat spinal cord , 1999, Neuroscience.

[17]  J. Calixto,et al.  The role of systemic, spinal and supraspinal l-arginine–nitric oxide–cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice. , 1999, Neuropharmacology.

[18]  Z. Kleinrok,et al.  Isobolographic analysis of interaction between intrathecal morphine and clonidine in the formalin test in rats. , 1997, European journal of pharmacology.

[19]  V. Arshavsky,et al.  cGMP signal termination. , 1996, Biochemical Society transactions.

[20]  Andrew Simon Bell,et al.  Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction , 1996 .

[21]  J C Gingell,et al.  Sildenafil, a novel effective oral therapy for male erectile dysfunction. , 1996, British journal of urology.

[22]  J. Sawynok,et al.  Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration. , 1995, European journal of pharmacology.

[23]  J. Beavo,et al.  Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.

[24]  D. Stanski,et al.  Pentobarbital‐morphine Anesthetic Interactions in Terms of Intensity of Noxious Stimulation Required for Arousal , 1993, Anesthesiology.

[25]  S. Ferreira,et al.  The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. , 1991, European journal of pharmacology.

[26]  J. Beavo,et al.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. , 1990, Trends in pharmacological sciences.

[27]  R. Tallarida,et al.  Manual of Pharmacologic Calculations: With Computer Programs , 1984 .

[28]  S. Ferreira,et al.  I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. , 1979, Prostaglandins.

[29]  T. Yaksh,et al.  Chronic catheterization of the spinal subarachnoid space , 1976, Physiology & Behavior.

[30]  C. S. Patil,et al.  Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil , 2006, InflammoPharmacology.

[31]  A. Perez,et al.  delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway. , 2005, Life sciences.

[32]  T. Yaksh,et al.  Anesthesia : biologic foundations , 1999 .